Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yining Du

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nanomaterials (Basel, Switzerland)|April 28, 2023
Advances in the Field of Two-Dimensional Crystal-Based PhotodetectorsXiaoling Ye, Yining Du, Mingyang Wang, et al.
Chemical Science|July 2, 2026
PFAS free chemically amplified resists enabled by low activation energy hydrocarbon cage monomersYizhou Liu, Matthew D Summersgill, Han-Hao Cheng, et al.
JAMA Oncology|May 13, 2022
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical TrialDebu Tripathy, Sara M Tolaney, Andrew D Seidman, et al.
The Lancet. Oncology|February 29, 2024
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 studyNaval G Daver, Pau Montesinos, Daniel J DeAngelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell NeoplasmNaveen Pemmaraju, Giovanni Marconi, Pau Montesinos, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nanomaterials (Basel, Switzerland)|April 28, 2023
Advances in the Field of Two-Dimensional Crystal-Based PhotodetectorsXiaoling Ye, Yining Du, Mingyang Wang, et al.
Chemical Science|July 2, 2026
PFAS free chemically amplified resists enabled by low activation energy hydrocarbon cage monomersYizhou Liu, Matthew D Summersgill, Han-Hao Cheng, et al.
JAMA Oncology|May 13, 2022
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical TrialDebu Tripathy, Sara M Tolaney, Andrew D Seidman, et al.
The Lancet. Oncology|February 29, 2024
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 studyNaval G Daver, Pau Montesinos, Daniel J DeAngelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell NeoplasmNaveen Pemmaraju, Giovanni Marconi, Pau Montesinos, et al.
Pageof 2